SCHEMBL24046928

SCHEMBL24046928

O=c1cc(-c2ccc(O)cc2)oc2c(Br)cc(Br)cc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 6/20 0.65
▸ CSNK2B P67870 6/20 0.65
▸ CSNK2A1 P68400 6/20 0.65
▸ TERT O14746 1/20 0.57
▸ KDM4E B2RXH2 4/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ CYP3A4 P08684 3/20 0.54
▸ HPGD P15428 3/20 0.54
▸ MAPT P10636 3/20 0.54
▸ IP6K2 Q9UHH9 2/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ CYP19A1 P11511 2/20 0.54
▸ HSD17B10 Q99714 2/20 0.54
▸ TP53 P04637 2/20 0.54
▸ MPO P05164 1/20 0.54
▸ MAOA P21397 1/20 0.54
▸ MAOB P27338 1/20 0.54
▸ MAPK1 P28482 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24046755 0.86 CSNK2A2 (0.73) CSNK2A2CSNK2BCSNK2A1TERTKDM4E
SCHEMBL21801314 0.86 CSNK2A2 (0.56) CSNK2A2CSNK2BCSNK2A1TERTKDM4E
SCHEMBL4649432 0.85 CSNK2A2 (0.58) CSNK2A2CSNK2BCSNK2A1CYP1A1CYP1A2
SCHEMBL4650589 0.85 GABRP (0.61) CSNK2A2CSNK2BCSNK2A1TERTKDM4E
SCHEMBL24046998 0.82 CSNK2A2 (0.72) CSNK2A2CSNK2BCSNK2A1TERT
SCHEMBL24046894 0.82 TNKS (0.56) CSNK2A2CSNK2BCSNK2A1CYP1A2CYP1B1
SCHEMBL24046752 0.80 CSNK2A2 (0.78) CSNK2A2CSNK2BCSNK2A1TERTKDM4E
SCHEMBL24046750 0.80 CSNK2A2 (0.63) CSNK2A2CSNK2BCSNK2A1TERTKDM4E
SCHEMBL24046757 0.80 CSNK2A2 (0.60) CSNK2A2CSNK2BCSNK2A1TERTKDM4E
SCHEMBL24046990 0.80 CSNK2A2 (0.50) CSNK2A2CSNK2BCSNK2A1TERTCYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021236578-A1 CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2021-11-25 — — WO disclosed
Send feedback